|
|
||||||||
1 Division of Life Sciences and 5 Department of Pathology, Hallym University, Chunchon 200-702; 3 Department of Food and Nutrition, Kyung Hee University, Seoul 130-701; and 4 Division of Applied Life Sciences, Graduate School, Gyeongsang National University, Chinju 660-701, Korea; and 2 Laboratory for Physiological Chemistry, University Medical Center Utrecht, 3584 CG Utrecht, Netherlands
A commercially available mixture of conjugated linoleic acid (CLA) isomers decreases colon cancer cell growth. We compared the individual potencies of the two main isomers in this mixture [cis-9,trans-11 (c9t11) and trans-10,cis-12 (t10c12)] and assessed whether decreased cell growth is related to changes in secretion of insulin-like growth factor II (IGF-II) and/or IGF-binding proteins (IGFBPs), which regulate Caco-2 cell proliferation. Cells were incubated in serum-free medium with different concentrations of the individual CLA isomers. t10c12 CLA dose dependently decreased viable cell number (55 ± 3% reduction 96 h after adding 5 µM t10c12 CLA). t10c12 CLA induced apoptosis and decreased DNA synthesis, whereas c9t11 CLA had no effect. Immunoblot analysis of 24-h serum-free conditioned medium using a monoclonal anti-IGF-II antibody revealed that Caco-2 cells secreted both a mature 7,500 molecular weight (Mr) IGF-II and higher Mr forms of IGF-II. The levels of the higher Mr and the mature form of IGF-II were decreased 50 ± 3% and 22 ± 2%, respectively, by 5 µM t10c12 CLA. c9t11 CLA had no effect. Ligand blot analysis of conditioned medium using 125I-labeled IGF-II revealed that t10c12 CLA slightly decreased IGFBP-2 production; c9t11 CLA had no effect. Exogenous IGF-II reversed t10c12 CLA-induced growth inhibition and apoptosis. These results indicate that CLA-inhibited Caco-2 cell growth is caused by t10c12 CLA and may be mediated by decreasing IGF-II secretion in Caco-2 cells.
insulin-like growth factor binding proteins; apoptosis
This article has been cited by other articles:
![]() |
N. S. Kelley, N. E. Hubbard, and K. L. Erickson Conjugated Linoleic Acid Isomers and Cancer J. Nutr., December 1, 2007; 137(12): 2599 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Murphy, G. J. Hooiveld, M. Muller, R. A. Calogero, and K. D. Cashman Conjugated Linoleic Acid Alters Global Gene Expression in Human Intestinal-Like Caco-2 Cells in an Isomer-Specific Manner J. Nutr., November 1, 2007; 137(11): 2359 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rosberg-Cody, M. C. Johnson, G. F. Fitzgerald, P. R. Ross, and C. Stanton Heterologous expression of linoleic acid isomerase from Propionibacterium acnes and anti-proliferative activity of recombinant trans-10, cis-12 conjugated linoleic acid Microbiology, August 1, 2007; 153(8): 2483 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kim, S. Y. Park, H.-K. Shin, D. Y. Kwon, Y.-J. Surh, and J. H. Y. Park Activation of Caspase-8 Contributes to 3,3'-Diindolylmethane-Induced Apoptosis in Colon Cancer Cells J. Nutr., January 1, 2007; 137(1): 31 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Lim, Y. Jeong, A. L. Tyner, and J. H. Y. Park Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G66 - G75. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Lee, K. Yamaguchi, J.-S. Kim, T. E. Eling, S. Safe, Y. Park, and S. J. Baek Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner Carcinogenesis, May 1, 2006; 27(5): 972 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Cho, E. J. Kim, S. S. Lim, M. K. Kim, M.-K. Sung, J.-S. Kim, and J. H. Y. Park Trans-10,cis-12, Not cis-9,trans-11, Conjugated Linoleic Acid Inhibits G1-S Progression in HT-29 Human Colon Cancer Cells J. Nutr., April 1, 2006; 136(4): 893 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lu, J. i. Jung, H. J. Cho, D. Y. Lim, H. S. Lee, H. S. Chun, D. Y. Kwon, and J. H. Park Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells J. Nutr., December 1, 2005; 135(12): 2884 - 2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Burdge, B. Lupoli, J. J. Russell, S. Tricon, S. Kew, T. Banerjee, K. J. Shingfield, D. E. Beever, R. F. Grimble, C. M. Williams, et al. Incorporation of cis-9,trans-11 or trans-10,cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men J. Lipid Res., April 1, 2004; 45(4): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kim, I.-J. Kang, H. J. Cho, W. K. Kim, Y.-L. Ha, and J. H. Y. Park Conjugated Linoleic Acid Downregulates Insulin-Like Growth Factor-I Receptor Levels in HT-29 Human Colon Cancer Cells J. Nutr., August 1, 2003; 133(8): 2675 - 2681. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Cho, W. K. Kim, E. J. Kim, K. C. Jung, S. Park, H. S. Lee, A. L. Tyner, and J. H. Y. Park Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G996 - G1005. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |